Try our Investor Tool
Login
Sign Up

Login
Sign Up

Features
Pricing
RNS/News
Contact

Try our Investor Tool
Login
Sign Up

Search

Providers
Companies

⨯

Search

Providers
Companies

⨯

Features
Pricing
Event Hub
RNS/News
Short Interest
Contact

Research >: The Monthly May 2019

03 May 2019

The Monthly May 2019

Time Finance plc (TIME:LON), 26.5 | Advanced Oncotherapy Plc (AVO:LON), 34.5 | AJ Bell Plc (AJB:LON), 417 | Arbuthnot Banking Group PLC (ARBB:LON), 1,040 | Chamberlin plc (CMH:LON), 9.5 | City of London Investment Group PLC (CLIG:LON), 531 | DP Poland PLC (DPP:LON), 8.8 | Filta Group Holdings PLC (FLTA:LON), 160 | Gateley (Holdings) Plc (GTLY:LON), 200 | Genedrive Plc (GDR:LON), 47.5 | Haydale Graphene Industries Plc (HAYD:LON), 7.6 | Koovs (KOOV:LON), 0 | Lightwaverf (LWRF:LON), 0 | Morses Club Plc (MCL:LON), 93.6 | Murgitroyd Group (MUR:LON), 0 | Oxford BioMedica plc (OXB:LON), 1,277 | Palace Capital plc (PCA:LON), 260 | Primary Health Properties PLC (PHP:LON), 157 | R.E.A. Holdings plc (RE:LON), 54.0 | Shield Therapeutics Plc (STX:LON), 51.5 | 600 Group PLC (SIXH:LON), 15.8 | Tissue Regenix Group plc (TRX:LON), 0.6 | Titon Holdings Plc (TON:LON), 137 | Volta Finance Limited (VTA:LON), 608 | Warpaint London PLC (W7L:LON), 158

- Hardman & Co Research Team
- 40 pages

Stock Image

Stock Image

How small- and mid-cap quoted companies make a substantial contribution to markets, employment and tax revenues.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.

Already a member? Log in here

The Monthly May 2019

Time Finance plc (TIME:LON), 26.5 | Advanced Oncotherapy Plc (AVO:LON), 34.5 | AJ Bell Plc (AJB:LON), 417 | Arbuthnot Banking Group PLC (ARBB:LON), 1,040 | Chamberlin plc (CMH:LON), 9.5 | City of London Investment Group PLC (CLIG:LON), 531 | DP Poland PLC (DPP:LON), 8.8 | Filta Group Holdings PLC (FLTA:LON), 160 | Gateley (Holdings) Plc (GTLY:LON), 200 | Genedrive Plc (GDR:LON), 47.5 | Haydale Graphene Industries Plc (HAYD:LON), 7.6 | Koovs (KOOV:LON), 0 | Lightwaverf (LWRF:LON), 0 | Morses Club Plc (MCL:LON), 93.6 | Murgitroyd Group (MUR:LON), 0 | Oxford BioMedica plc (OXB:LON), 1,277 | Palace Capital plc (PCA:LON), 260 | Primary Health Properties PLC (PHP:LON), 157 | R.E.A. Holdings plc (RE:LON), 54.0 | Shield Therapeutics Plc (STX:LON), 51.5 | 600 Group PLC (SIXH:LON), 15.8 | Tissue Regenix Group plc (TRX:LON), 0.6 | Titon Holdings Plc (TON:LON), 137 | Volta Finance Limited (VTA:LON), 608 | Warpaint London PLC (W7L:LON), 158

Published: 03 May 2019
Author: Hardman & Co Research Team
Pages: 40

How small- and mid-cap quoted companies make a substantial contribution to markets, employment and tax revenues.

More Content

More Content

Dividend recovery ahead of expectations

Companies: Palace Capital plc

Morses Club (LON:MCL) Presenting at the Proactive One2One Virtual Forum

Companies: Morses Club Plc

Good H1 strategic progress & positive momentum heading into H2

Companies: DP Poland PLC

Shield Therapeutics says OTCQX Best Market listing ahead of Accrufer US launch has 'great potential'

Companies: Shield Therapeutics Plc

Palace Capital - HQ completion opens strong growth opportunity

Companies: Palace Capital plc

Useful Links

Features
Pricing
RNS/Newswires Feeds
Providers Hub
Company Hub

Account

Login
Free Trial - Join Now
Contact

Follow us on Linkedin Follow us on Twitter

Share:

Copyright © 2021 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top

Home
Features
Pricing
Event Hub
RNS/News
Short Interest Tracker
Blogs
Ideas & Picks
Explore Content
Providers
Contact
Sign Up
Sign In